RATIONALE: Rodents are usually used to assess the ability of antipsychotic drugs to antagonize hyperlocomotion induced by dopamine agonists, such as the psychostimulant d-amphetamine. However, the substantial differences between rodents and humans may hinder extrapolation of experimental results to humans. For this reason, we speculated that Göttingen miniature pigs, which show strong physiological and genetic homology with humans, might be a better model for investigating the effects of antipsychotics. To investigate this, we determined whether d-amphetamine induced hyperlocomotion in miniature pigs and whether this effect was reversible by antipsychotics. MATERIALS AND METHODS: d-amphetamine was tested in the dose range of 0.2 to 2.0 mg kg(-1) for its ability to induce hyperactivity in the open field, and the effects of two antipsychotics, haloperidol and risperidone, on amphetamine-induced hyperactivity were examined. RESULTS: d-amphetamine increased open-field activity at 0.2, 0.4, and 0.7 mg kg(-1) s.c. but not at higher doses. The stimulation of open-field activity induced by 0.4 mg kg(-1) s.c. d-amphetamine was antagonized by haloperidol and risperidone (0.01 and 0.04 mg kg(-1) s.c.). CONCLUSION: d-amphetamine-induced hyperlocomotion in miniature pigs may be a useful model for studying the effect of putative antipsychotics.
RATIONALE: Rodents are usually used to assess the ability of antipsychotic drugs to antagonize hyperlocomotion induced by dopamine agonists, such as the psychostimulant d-amphetamine. However, the substantial differences between rodents and humans may hinder extrapolation of experimental results to humans. For this reason, we speculated that Göttingen miniature pigs, which show strong physiological and genetic homology with humans, might be a better model for investigating the effects of antipsychotics. To investigate this, we determined whether d-amphetamine induced hyperlocomotion in miniature pigs and whether this effect was reversible by antipsychotics. MATERIALS AND METHODS:d-amphetamine was tested in the dose range of 0.2 to 2.0 mg kg(-1) for its ability to induce hyperactivity in the open field, and the effects of two antipsychotics, haloperidol and risperidone, on amphetamine-induced hyperactivity were examined. RESULTS:d-amphetamine increased open-field activity at 0.2, 0.4, and 0.7 mg kg(-1) s.c. but not at higher doses. The stimulation of open-field activity induced by 0.4 mg kg(-1) s.c. d-amphetamine was antagonized by haloperidol and risperidone (0.01 and 0.04 mg kg(-1) s.c.). CONCLUSION:d-amphetamine-induced hyperlocomotion in miniature pigs may be a useful model for studying the effect of putative antipsychotics.
Authors: Laurent Bardin; Agnès Auclair; Mark S Kleven; Eric P M Prinssen; Wouter Koek; Adrian Newman-Tancredi; Ronan Depoortère Journal: Behav Pharmacol Date: 2007-03 Impact factor: 2.293
Authors: Nanna Marie Lind; Anette Moustgaard; Jacob Jelsing; Gabor Vajta; Paul Cumming; Axel K Hansen Journal: Neurosci Biobehav Rev Date: 2007-03-04 Impact factor: 8.989
Authors: R E Nordquist; L J M J Vanderschuren; A J Jonker; M Bergsma; T J de Vries; C M A Pennartz; P Voorn Journal: Psychopharmacology (Berl) Date: 2008-03-18 Impact factor: 4.530
Authors: Sarah Sullivan; Stuart H Friess; Jill Ralston; Colin Smith; Kathleen J Propert; Paul E Rapp; Susan S Margulies Journal: J Neurotrauma Date: 2013-04-03 Impact factor: 5.269
Authors: Joseph Darbellay; Brian Cox; Kenneth Lai; Mario Delgado-Ortega; Colette Wheler; Donald Wilson; Stewart Walker; Gregory Starrak; Duncan Hockley; Yanyun Huang; George Mutwiri; Andrew Potter; Matthew Gilmour; David Safronetz; Volker Gerdts; Uladzimir Karniychuk Journal: EBioMedicine Date: 2017-09-21 Impact factor: 8.143
Authors: Ivan Trus; Daniel Udenze; Brian Cox; Nathalie Berube; Rebecca E Nordquist; Franz Josef van der Staay; Yanyun Huang; Gary Kobinger; David Safronetz; Volker Gerdts; Uladzimir Karniychuk Journal: PLoS Pathog Date: 2019-11-14 Impact factor: 6.823